ABBV vs VRT: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Vertiv Holdings Co — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Vertiv Holdings Co · Industrials
$253.28
+8.2% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
VRT has more upside to fair value
(+8.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
VRT |
| Current Price |
$261.70 |
$253.28 |
| Fair Value Estimate |
$259.04 |
$274.15 |
| Upside to Fair Value |
-1.0%
|
+8.2%
|
| Market Cap |
$462.4B |
$97.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
38.8x
|
| Price / Sales |
7.2x
|
8.5x
|
| Price / FCF |
23.6x
|
33.3x
|
| Revenue Growth YoY |
+10.2%
|
+24.1%
|
| Gross Margin |
71.5%
|
37.5%
|
| Operating Margin |
29.3%
|
19.1%
|
| Return on Equity |
-136.5%
|
42.1%
|
| Dividend Yield |
2.61% |
0.1% |
| FCF Yield |
4.25%
|
3.0%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Vertiv Holdings Co is a global provider of critical digital infrastructure for data centers, communication networks, and industrial applications, spanning AC and DC power management, thermal cooling, integrated rack systems, and lifecycle services under brands including Liebert, NetSure, Geist, and Avocent, with roughly 34,000 employees and a global footprint across the Americas, Asia Pacific, an…
Accumulation Zones
| Metric |
ABBV |
VRT |
| Zone Low |
$194.28 |
$205.61 |
| Zone High |
$220.18 |
$233.03 |
| In Buy Zone? |
No
|
No
|